• 论著 • 上一篇    下一篇

低分子肝素联合低分子右旋糖酐治疗羊水过少的研究

周玮1,熊正爱2,刘颖2   

  1. 1. 重庆医科大学附属第二医院妇产科
    2. 重庆医科大学附属第二医院
  • 收稿日期:2010-09-08 修回日期:2011-03-03 出版日期:2011-08-15 发布日期:2011-08-15
  • 通讯作者: 周玮

Research on the effects of low molecular weight heparin combined with dextran-40 on oligohydramnios

  • Received:2010-09-08 Revised:2011-03-03 Published:2011-08-15 Online:2011-08-15
  • Contact: Wei ZHOU

摘要: 摘要 目的:观察应用低分子肝素联合低分子右旋糖酐治疗羊水过少中的临床效果以及安全性。方法:73例羊水过少孕妇随机分为3组,联合治疗组21例予以低分子肝素0.4 mL皮下注射和5%低分子右旋糖酐500 mL静脉滴注;低分子肝素治疗组20例给予低分子肝素0.4 mL皮下注射;对照组32例予以能量合剂(5%葡萄糖500 mL,三磷酸腺苷 40 mg,肌苷0.4 g,辅酶A 100 u)和10%复方氨基酸(18AA)250 mL静脉滴注。比较各组治疗前后羊水指数和相关凝血象指标变化。结果:经过一个疗程的治疗,联合治疗组、低分子肝素组的好转率均明显高于对照组,差异有统计学意义(P<0.05)。联合治疗组羊水指数(AFI)优于低分子肝素组(P<0.05)。治疗前后孕妇凝血相关指标比较,差异无统计学 ( 均P>0.05),未发现治疗引起的凝血功能障碍。结论:低分子肝素联合低分子右旋糖酐是治疗妊娠期羊水过少的有效方法,对母儿均比较安全。

关键词: 羊水过少, 右旋糖酐, 肝素 低分子量, 治疗 临床研究性

Abstract: Abstract Objective: To investigate the effects and safety of low molecular weight heparin combined with dextran-40 on pregnant women with oligohydramnios. Methods: A total of 73 pregnant women who were diagnosed as oligohydramnios were randomized into combined therapy group(n=21), low molecular weight heparin (LMWP) group(n=21) and control group(n=32). The combined therapy group was treated with 0.4 mL of LMWP and 500 mL of 5% dextran-40. LMPW group was treated with 0.4 mL of LMPW only. The control group was given 500 mL of 5% glucose infused with 40 mg of Adenosine triphosphate,0.4 g of carnine,100 u of coenzyme A and 250 mL of compound amino acids. Amniotic fluid index(AFI) and coagulogram markers were measured after a course. Results:The improvement rate were significant higher in combined therapy group(90.5%) and LMWP group(80.0%) than in control group(46.9%)(P<0.05), but there was no difference between these 2 groups(P>0.05). The average increasing volume of AFI was significant different between the 2 groups(P<0.05). The combined therapy group(4.41±0.63) was better than LMWP group(3.95±0.57). There was no difference in blood coagulation indication between before and after treatment in each group(P>0.05). Conclusion: LMWP combined with dextran-40 could improve volume of amniotic fluid effectively in patients suffered with oligohydramnios, and it was safe to both mothers and fetuses.

Key words: oligohydramnios, dextrans, heparin, low-molecular-weight, therapies, investigational